FDA Adverse Event Malfunction Summary report: N

SYRINGE ORAL 3ML AMBER

MDR report key: 11742502 · Received April 28, 2021

Report

Report Number
1213809-2021-00276
Event Type
Malfunction
Date Received
April 28, 2021
Date of Event
March 31, 2021
Report Date
May 21, 2021
Manufacturer
BECTON DICKINSON MEDICAL SYSTEMS
Product Code
KYW
PMA / PMN Number
EXEMPT
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

H6: INVESTIGATION SUMMARY: THE 3ML ORAL PRODUCT ASSOCIATED WITH THIS COMPLAINT IS MANUFACTURED AND SOLD AS NON-STERILE. THEREFORE, STERILITY TESTING IS NOT APPLICABLE, AND NO DEFECT IS CONFIRMED. A DEVICE HISTORY RECORD REVIEW SHOWED NO REJECTED INSPECTIONS OR QUALITY ISSUES DURING THE PRODUCTION OF THE PROVIDED LOT NUMBER THAT COULD HAVE CONTRIBUTED TO THE REPORTED DEFECT.

Description of Event or Problem · 0

IT WAS REPORTED THAT SYRINGE ORAL 3ML AMBER HAD STERILITY ISSUES. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: MICROBIAL TESTING OF 3 ML ORAL SYRINGES HAS RETURNED OUT OF SPECIFICATION RESULTS OF 172 CFU/10 SYRINGES (TAMC SPECIFICATION LIMIT 102/10 SYRINGES).

Additional Manufacturer Narrative · 1

DATE OF EVENT: UNKNOWN. THE DATE RECEIVED BY MANUFACTURER HAS BEEN USED FOR THIS FIELD. MEDICAL DEVICE EXPIRATION DATE: NA. A DEVICE EVALUATION AND/OR DEVICE HISTORY REVIEW IS ANTICIPATED, BUT IS NOT COMPLETE. UPON COMPLETION, A SUPPLEMENTAL REPORT WILL BE FILED.

Description of Event or Problem · 1

IT WAS REPORTED THAT SYRINGE ORAL 3ML AMBER HAD STERILITY ISSUES. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: MICROBIAL TESTING OF 3 ML ORAL SYRINGES HAS RETURNED OUT OF SPECIFICATION RESULTS OF 172 CFU/10 SYRINGES (TAMC SPECIFICATION LIMIT 102/10 SYRINGES).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
632680 SYRINGE ORAL 3ML AMBER LIQUID MEDICATION DISPENSER KYW BECTON DICKINSON MEDICAL SYSTEMS 0114465

Patients

Seq Age Sex Outcome Treatment
1